BiOrion has raised additional funding from one of its founders for a clinical phase 2 diagnostic-imaging program in cardiac fibrosis patients

by admin | Feb 21, 2022 | News

BiOrion Technologies BV has raised additional funding from one of its founders for a clinical phase 2 diagnostic-imaging program in cardiac fibrosis patients. BiOrion Technologies BV (BiOrion), a biopharmaceutical drug discovery company, develops products for...

Intern Life Sciences

by admin | Jan 27, 2022 | Positions

Job description: Intern Life SciencesType: 80% – 100%, dependent on requirements training programLocation: Groningen The NetherlandsDate: Immediate About the role  At BiOrion we are able to support up to 2 internships simultaneously. The Intern at BiOrion works...

VP Business Development

by admin | Jan 21, 2022 | Positions

Job description: VP Business Development Type: 20% – 60%, on management contractLocation: Groningen The NetherlandsDate: Immediate About the role   The VP Business Development is responsible for managing and developing BiOrion’s business development...

A consortium including BiOrion is awarded a EUROSTARS grant of a EUR 1.7 million for diagnostic imaging of colorectal cancer

by admin | Dec 11, 2020 | News

First patient enrolled in a PET-imaging study with BiOrion’s 68-Gallium labeled PDGF beta receptor binding bicyclic peptide BOT5035 in patients with organ fibrosis.

by admin | Sep 30, 2020 | News

BiOrion Technologies announced today that a first fibrosis patient has been enrolled in the first-in-human PET imaging study with 68-Gallium labeled PDGF beta receptor binding bicyclic peptide BOT5035. Herman Steen, CEO of BiOrion, “The enrollment of the first patient...